IRIS
CHIAPPINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.253
AS - Asia 1.016
EU - Europa 616
SA - Sud America 212
AF - Africa 27
OC - Oceania 3
Totale 3.127
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.195
SG - Singapore 525
CN - Cina 200
BR - Brasile 177
VN - Vietnam 142
DE - Germania 122
IT - Italia 121
RU - Federazione Russa 110
IE - Irlanda 62
SE - Svezia 40
FI - Finlandia 32
HK - Hong Kong 32
IN - India 32
CA - Canada 28
MX - Messico 28
GB - Regno Unito 26
FR - Francia 18
AT - Austria 17
AR - Argentina 16
ES - Italia 14
NL - Olanda 14
PL - Polonia 13
KR - Corea 12
BD - Bangladesh 11
ZA - Sudafrica 10
LT - Lituania 9
TR - Turchia 9
JP - Giappone 8
IQ - Iraq 7
UZ - Uzbekistan 7
EC - Ecuador 6
MA - Marocco 5
EG - Egitto 4
HU - Ungheria 4
PK - Pakistan 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
IL - Israele 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
JO - Giordania 2
KZ - Kazakistan 2
MN - Mongolia 2
PS - Palestinian Territory 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.127
Salva come PNG Salva come JPEG
Città #
Singapore 415
San Jose 238
Ashburn 173
Munich 85
Dallas 73
Dublin 62
The Dalles 59
Beijing 54
Chandler 54
Los Angeles 48
Ho Chi Minh City 46
São Paulo 36
Santa Clara 33
New York 29
Hong Kong 27
Hanoi 24
Rome 21
Council Bluffs 19
Princeton 19
Hefei 18
Redondo Beach 18
Tongling 18
Orem 17
Buffalo 16
Chennai 15
Denver 15
Montreal 15
Turku 13
Washington 13
Atlanta 12
Frankfurt am Main 12
Warsaw 12
Boardman 11
Helsinki 11
Da Nang 10
Düsseldorf 10
Moscow 10
Nuremberg 9
Toronto 9
Altamura 8
Boston 8
Guangzhou 8
Johannesburg 8
Lappeenranta 8
Mexico City 8
Tokyo 8
Vienna 8
Amsterdam 7
San Francisco 7
Seoul 7
Haiphong 6
Houston 6
Lauterbourg 6
Phoenix 6
Silvi 6
Tashkent 6
Ankara 5
Brooklyn 5
Chicago 5
Mumbai 5
Stockholm 5
Augusta 4
Baghdad 4
Campinas 4
Gwangju 4
Hải Dương 4
Manchester 4
New Delhi 4
Phủ Lý 4
Portsmouth 4
Querétaro 4
Seattle 4
Belo Horizonte 3
Budapest 3
Bắc Giang 3
Camerino 3
Can Tho 3
City of London 3
Curitiba 3
London 3
Milan 3
Norfolk 3
Paris 3
Poplar 3
Porto Alegre 3
Rio de Janeiro 3
San Benedetto del Tronto 3
Scandicci 3
St Louis 3
Xiamen 3
Asunción 2
Baku 2
Bari 2
Bismarck 2
Bogotá 2
Bologna 2
Brussels 2
Cairo 2
Cao Lanh 2
Casalbordino 2
Totale 2.043
Salva come PNG Salva come JPEG
Nome #
Misuse of Anticholinergic Medications: A Systematic Review 99
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 97
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 96
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 96
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 95
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 95
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 95
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report 94
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 93
Climate change, biodiversity loss and mental health: a global perspective 92
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 91
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 89
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 84
New psychoactive substances and suicidality: A systematic review of the current literature 84
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 84
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 82
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 82
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 81
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 80
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 80
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 79
Brexpiprazole as a new approach of treatment in somatization disorder 79
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 77
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 75
Opioid painkiller dependence in a sample of elderly medical inpatients 74
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 72
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 68
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 67
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 63
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 60
Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review 59
The benzydamine experience: a systematic review of benzydamine abuse 58
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 57
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 57
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 56
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 54
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 52
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 51
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 50
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality 42
Emerging strategies and clinical recommendations for the management of novel depression subtypes 39
Alcohol vs. Cocaine: Impulsivity and Alexithymia in Substance Use Disorder 15
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlates 12
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes 12
Exploring Dual Diagnoses: Psychopathological Characteristics in the Co-Occurrence of Schizophrenia and Addiction – A Scoping Review 12
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 12
Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia 12
Cannabis use and psychotic-like experiences: A systematic review of biological vulnerability, potency effects, and clinical trajectories 11
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature 11
Novel psychoactive substances and psychosis: A comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment 11
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes 10
Semaglutide for Craving Reduction in a Cocaine Dependent Patient: A Case Report 10
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data 9
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective 9
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literature 7
Eco-Anxiety and Mental Health: Correlates of Climate Change Distress 7
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy 5
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database 4
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor 4
Totale 3.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 1 0 0 0 9 2 11 1 18
2022/2023199 9 25 12 10 19 37 11 17 45 4 2 8
2023/2024250 11 18 34 12 29 52 25 10 11 14 5 29
2024/2025724 60 88 51 16 27 16 32 23 69 91 125 126
2025/20262.026 174 101 174 286 236 112 275 194 287 187 0 0
Totale 3.251